{"id":8126,"date":"2023-11-09T07:00:00","date_gmt":"2023-11-09T07:00:00","guid":{"rendered":"https:\/\/www.acarix.com\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/"},"modified":"2024-11-18T19:04:45","modified_gmt":"2024-11-18T19:04:45","slug":"acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/","title":{"rendered":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p class=\"mfn-wp-retain\"><strong>Fortsatt momentum i USA och st&auml;rkt finansiering p&aring; plats<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p class=\"mfn-wp-retain\">Vi &auml;r n&ouml;jda med int&auml;ktstillv&auml;xten i USA under Q3, d&auml;r vi g&ouml;r betydande investeringar f&ouml;r att &ouml;ka f&ouml;rs&auml;ljningen via v&aring;r kostnadseffektiva hybridf&ouml;rs&auml;ljningsmodell. I syfte att ytterligare &ouml;ka tillv&auml;xttakten i USA planeras f&ouml;r&auml;ndringar i f&ouml;rs&auml;ljningsorganisationen. Vi fokuserar f&ouml;r n&auml;rvarande p&aring; de tv&aring; Veterans Affairs (VA)-systemen i delstaten Louisiana, som redan k&ouml;pt CADScor-system, medan n&aring;gra andra VA:s s&ouml;ker godk&auml;nnanden och medel f&ouml;r CADScor-anv&auml;ndning. Vi g&ouml;r ocks&aring; p&aring;tagliga framsteg med ett specifikt, stort integrerat sjukhussystem (IDN) samtidigt som vi forts&auml;tter att g&ouml;ra framsteg med att utveckla ytterligare aff&auml;rsm&ouml;jligheter.<\/p>\n<p><em>Utdrag ur tf. VD Fred Colens kommentar till del&aring;rsrapporten.<\/em><\/p>\n<p class=\"mfn-wp-retain\"><strong>Tredje kvartalet 2023 j&auml;mf&ouml;rt med samma period 2022<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Int&auml;kterna under tredje kvartalet uppgick till 1 573 kSEK (1 164). Bruttoresultatet uppgick till 1 292 kSEK (921) vilket motsvarar en bruttomarginal om 82 % (79 %) och en f&ouml;rb&auml;ttring med 3 procentenheter j&auml;mf&ouml;rt med samma period 2022.<\/li>\n<li>Under kvartalet s&aring;ldes 14 (14) CADScor&reg;System och 1 903 (1 812) patcher.<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 18 517 kSEK (21 653).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till -17 291 kSEK (-21 106).<\/li>\n<li>Periodens nettokassafl&ouml;de uppgick till -16 705 kSEK (-21 218).<\/li>\n<li>Resultat per aktie uppgick till -0,04 SEK (-0,08).<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>F&ouml;rsta nio m&aring;naderna 2023 j&auml;mf&ouml;rt med samma period 2022<\/strong><\/p>\n<ul>\n<li>Int&auml;kterna under f&ouml;rsta nio m&aring;naderna uppgick till 5 067 kSEK (4 169). Bruttoresultatet uppgick till 4 270 kSEK (3 292) vilket motsvarar en bruttomarginal om 84 % (79 %) och en f&ouml;rb&auml;ttring med 5 % enheter j&auml;mf&ouml;rt med samma period 2022.<\/li>\n<li>Under perioden s&aring;ldes 36 (48) CADScor&reg;System och 7 120 (6 252) patcher.<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 59 825 kSEK (57 153).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till -55 775 kSEK (-54 372).<\/li>\n<li>Nettokassafl&ouml;det uppgick till -2 453 kSEK (12 372).<\/li>\n<li>Likvida medel uppgick till 9 246 kSEK (29 409).<\/li>\n<li>Resultat per aktie uppgick till -0,13 SEK (-0,22). Inga utsp&auml;dningseffekter uppkom.<\/li>\n<li>Antal aktier per balansdagen uppg&aring;r till 452 868 010 (251 972&nbsp;194).<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser under tredje kvartalet 2023<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Den 28 augusti meddelade bolaget utn&auml;mningen av Dr. Deepak R. Talreja, MD, som ny medicinsk r&aring;dgivare. Med en imponerande bakgrund inom kardiologi tillf&ouml;r Dr. Talreja bred kunskap och expertis till Acarix, vilket ytterligare st&auml;rker bolagets engagemang f&ouml;r att transformera tidig hj&auml;rtdiagnostik med hj&auml;lp av banbrytande akustisk och AI-baserad teknologi.<\/li>\n<li>Den 29 augusti meddelade bolaget betydande framsteg i anv&auml;ndningen av CADScor System inom Veterans Administration (VA), den st&ouml;rsta v&aring;rdgivaren i USA. VA Healthcare System i syd&ouml;stra Louisiana har nu godk&auml;nt inkluderingen av CADScor System i dess Standard Operating Procedure (SOP) f&ouml;r riskstratifiering av symtomatiska patienter med misst&auml;nkt kransk&auml;rlssjukdom (CAD). Vidare har ytterligare ett VA sjukhus &#8211; Biloxi VA Medical Center (VA Gulf Coast Veterans Healthcare System) lagt f&ouml;rsta order p&aring; CADScor System med tillh&ouml;rande patcher.<\/li>\n<li>Den 4 september meddelade bolaget samarbetet med Maeva Health, under ledning av Dr. Peter Svalander, VD, f&ouml;r lansering av CADScor-systemet p&aring; Mauritius och vidare ut p&aring; den expansiva &ouml;stafrikanska marknaden med en befolkning p&aring; &ouml;ver 485 miljoner. Partnerskapet med Maeva resulterade i en f&ouml;rsta order p&aring; tre CADScor System.<\/li>\n<li>Den 11 september meddelade bolaget om beslut g&auml;llande f&ouml;retr&auml;desemission om ca 54 MSEK, fullt garanterat av bland annat en dansk life science fond.<\/li>\n<li>Den 27 september meddelade bolaget om den f&ouml;rsta aff&auml;ren inom osteopatisk medicin p&aring; USA-marknaden. Den initiala ordern av CADScor&reg;System fr&aring;n Legacy Medical LLC, bel&auml;gen i delstaten Georgia, &auml;r ytterligare en viktig milstolpe i bolagets p&aring;g&aring;ende kommersialiseringsarbete p&aring; den amerikanska marknaden.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser efter den 30 september 2023<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Den 10 oktober meddelade bolaget att VD Helen Ljungdahl Round sjukskrivits f&ouml;r behandling av cancer under en f&ouml;rv&auml;ntad period om cirka sex m&aring;nader. Styrelsen har med omedelbar verkan utsett Fred Colen till tillf&ouml;rordnad VD under Helens sjukskrivning.<\/li>\n<li>Den 20 oktober meddelade bolaget det slutliga utfallet i nyemissionen av units, best&aring;ende av aktier och teckningsoptioner av serie 2024:U1 (TO2) och serie 2024:U2 (TO3), med f&ouml;retr&auml;desr&auml;tt f&ouml;r befintliga aktie&auml;gare (&rdquo;F&ouml;retr&auml;desemissionen&rdquo;) som avslutades den 18 oktober 2023. Totalt 67 126 093 units, motsvarande cirka 74,1 procent av F&ouml;retr&auml;desemissionen, tecknades med och utan st&ouml;d av unitr&auml;tter. D&auml;rmed tilldelas de garanter som l&auml;mnat toppgarantier totalt 23 447 509 units, motsvarande cirka 25,9 procent av F&ouml;retr&auml;desemissionen. Acarix tillf&ouml;rs genom F&ouml;retr&auml;desemissionen sammanlagt cirka 54,3 MSEK f&ouml;re avdrag av kostnader h&auml;nf&ouml;rliga till F&ouml;retr&auml;desemissionen.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\">L&auml;nk till rapporten: <a href=\"https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar\" rel=\"noopener\" target=\"_blank\">https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-5f6793025012\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">F&ouml;r mer information, kontakta:<\/strong><br \/>Fred Colen, tf. VD, email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ja928lyd5LVtH4Zqz3RIoAP_vZ4DwD4jGGSS8irkeyApUfYtjFhf7OEe4gNScgnB2UBNq2dY0DN26ofiUpN4WG_gdBET6JivdcXqFArn7NQ=\" rel=\"noopener\" target=\"_blank\">fred.colen@acarix.com<\/a>&nbsp;<br \/>Christian Lindholm, CFO, tel +46&nbsp;705 118333, email <a href=\"mailto:christian.lindholm@acarix.com\" rel=\"noopener\" target=\"_blank\">christian.lindholm@acarix.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-ddf9d1ef3849\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Om Acarix<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">Acarix &auml;r ett svenskt medicintekniskt bolag som utvecklar innovativa l&ouml;sningar f&ouml;r snabb AI-baserad uteslutning av kransk&auml;rlssjukdom (CAD). Det CE-m&auml;rkta CADScor&reg; System, som &auml;ven har f&aring;tt DeNovo-godk&auml;nnande fr&aring;n FDA, &auml;r avsett f&ouml;r patienter som upplever br&ouml;stsm&auml;rta med misst&auml;nkt kransk&auml;rlssjukdom, och har utformats f&ouml;r att bidra till att minska miljontals fall av on&ouml;dig, invasiv och kostsam diagnostik. CADScor System anv&auml;nder avancerad akustik och AI-teknik f&ouml;r att p&aring; ett icke-invasivt s&auml;tt utesluta CAD p&aring; mindre &auml;n 10 minuter, med minst 96 % s&auml;kerhet. CADScor-systemet har anv&auml;nts p&aring; mer &auml;n 29 000 patienter och rekommenderas som ett f&ouml;rstahands diagnostiskt hj&auml;lpmedel enligt beskrivningen i det kliniska arbetsfl&ouml;det som utvecklats i samarbete med American College of Cardiology (ACC). Acarix &auml;r noterat p&aring; Nasdaq First North Premier Growth Market (ticker: ACARIX). Erik Penser Bank AB (+46 8 463 83 00, <a href=\"mailto:certifiedadviser@redeye.se\" rel=\"noopener\" target=\"_blank\">certifiedadviser@penser.se<\/a>) &auml;r bolagets Certified Adviser. F&ouml;r mer information bes&ouml;k <a href=\"http:\/\/www.acarix.com.\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/deaa1752-6daf-4f16-ac80-4c5ff53ffbe7\/acarix-q3-2023-swe-final.pdf\" rel=\"noopener\" target=\"_blank\">Acarix Q3 2023 Swe Final<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/deaa1752-6daf-4f16-ac80-4c5ff53ffbe7\/acarix-q3-2023-swe-final.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/deaa1752-6daf-4f16-ac80-4c5ff53ffbe7\/acarix-q3-2023-swe-final.pdf?type=jpg\"><\/span>Acarix Q3 2023 Swe Final<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Fortsatt momentum i USA och st&auml;rkt finansiering p&aring; plats Vi &auml;r n&ouml;jda med int&auml;ktstillv&auml;xten i USA under Q3, d&auml;r vi<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[157,140,154,139,160,148,155,142],"tags":[],"class_list":["post-8126","post","type-post","status-publish","format-standard","hentry","category-mfn-report-interim","category-mfn-type-ir","category-mfn-regulatory-listing","category-mfn","category-mfn-report-interim-q3","category-mfn-regulatory","category-mfn-report","category-mfn-lang-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix\" \/>\n<meta property=\"og:description\" content=\"Fortsatt momentum i USA och st&auml;rkt finansiering p&aring; plats Vi &auml;r n&ouml;jda med int&auml;ktstillv&auml;xten i USA under Q3, d&auml;r vi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T19:04:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023\",\"datePublished\":\"2023-11-09T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:04:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/\"},\"wordCount\":1111,\"articleSection\":[\"Interim\",\"IR\",\"Listing Regulation\",\"News\",\"Q3\",\"Regulatory\",\"Report\",\"Swedish\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/\",\"name\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2023-11-09T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:04:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","og_description":"Fortsatt momentum i USA och st&auml;rkt finansiering p&aring; plats Vi &auml;r n&ouml;jda med int&auml;ktstillv&auml;xten i USA under Q3, d&auml;r vi","og_url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/","og_site_name":"Acarix","article_published_time":"2023-11-09T07:00:00+00:00","article_modified_time":"2024-11-18T19:04:45+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023","datePublished":"2023-11-09T07:00:00+00:00","dateModified":"2024-11-18T19:04:45+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/"},"wordCount":1111,"articleSection":["Interim","IR","Listing Regulation","News","Q3","Regulatory","Report","Swedish"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/","url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/","name":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2023-11-09T07:00:00+00:00","dateModified":"2024-11-18T19:04:45+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=8126"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8126\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=8126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=8126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=8126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}